v3.26.1
Condensed Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
ATM
Public offering
Public offering
Common Stock
Public offering
Additional Paid-in Capital
Balance at Dec. 31, 2024 $ 181,165 $ 6 $ 696,872 $ 57 $ (515,770)        
Balance (in shares) at Dec. 31, 2024   64,460,829              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 5,703   5,703            
Issuance of common stock             $ 161,745 $ 3 $ 161,742
Issuance of common stock (in shares)               22,258,064  
Exercise of stock options 213   213            
Exercise of stock options (in shares)   236,962              
Unrealized loss on marketable securities (60)     (60)          
Net loss (41,640)       (41,640)        
Balance at Mar. 31, 2025 307,126 $ 9 864,530 (3) (557,410)        
Balance (in shares) at Mar. 31, 2025   86,955,855              
Balance at Dec. 31, 2024 181,165 $ 6 696,872 57 (515,770)        
Balance (in shares) at Dec. 31, 2024   64,460,829              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (85,037)                
Balance at Jun. 30, 2025 269,270 $ 9 870,092 (24) (600,807)        
Balance (in shares) at Jun. 30, 2025   87,012,835              
Balance at Mar. 31, 2025 307,126 $ 9 864,530 (3) (557,410)        
Balance (in shares) at Mar. 31, 2025   86,955,855              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 5,347   5,347            
Exercise of stock options 215   215            
Exercise of stock options (in shares)   56,980              
Unrealized loss on marketable securities (21)     (21)          
Net loss (43,397)       (43,397)        
Balance at Jun. 30, 2025 269,270 $ 9 870,092 (24) (600,807)        
Balance (in shares) at Jun. 30, 2025   87,012,835              
Balance at Dec. 31, 2025 634,343 $ 11 1,362,496   (728,164)        
Balance (in shares) at Dec. 31, 2025   113,133,199              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 7,953   7,953            
Exercise of stock options 229   229            
Exercise of stock options (in shares)   38,197              
Net loss (53,839)       (53,839)        
Balance at Mar. 31, 2026 588,686 $ 11 1,370,678   (782,003)        
Balance (in shares) at Mar. 31, 2026   113,171,396              
Balance at Dec. 31, 2025 $ 634,343 $ 11 1,362,496   (728,164)        
Balance (in shares) at Dec. 31, 2025   113,133,199              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock (in shares)           0      
Exercise of stock options (in shares) 266,003                
Net loss $ (126,966)                
Balance at Jun. 30, 2026 525,083 $ 11 1,380,535 (333) (855,130)        
Balance (in shares) at Jun. 30, 2026   113,399,202              
Balance at Mar. 31, 2026 588,686 $ 11 1,370,678   (782,003)        
Balance (in shares) at Mar. 31, 2026   113,171,396              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 8,799   8,799            
Exercise of stock options 1,058   1,058            
Exercise of stock options (in shares)   227,806              
Unrealized loss on marketable securities (333)     (333)          
Net loss (73,127)       (73,127)        
Balance at Jun. 30, 2026 $ 525,083 $ 11 $ 1,380,535 $ (333) $ (855,130)        
Balance (in shares) at Jun. 30, 2026   113,399,202